Literature DB >> 15889371

A national survey of severe influenza-associated complications among children and adults, 2003-2004.

Laura Jean Podewils1, Laura A Liedtke, L Clifford McDonald, Jeffrey C Hageman, Larry J Strausbaugh, Thea K Fischer, Daniel B Jernigan, Timothy M Uyeki, Matthew J Kuehnert.   

Abstract

This report summarizes findings of a national survey conducted among infectious diseases consultants to assess complications associated with influenza during the 2003-2004 influenza season. The survey identified severe complications, including secondary infection with Staphylococcus aureus and deaths among children and adults, as well as perceived shortages in rapid diagnostic tests and influenza vaccine.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15889371     DOI： 10.1086/430424

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  10 in total

1.  Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza.

Authors:  Kevin T Shiley; Gregory Nadolski; Timothy Mickus; Neil O Fishman; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2010-07       Impact factor: 3.254

Review 2.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.

Authors:  Olivia Perwitasari; Xiuzhen Yan; Jason O'Donnell; Scott Johnson; Ralph A Tripp
Journal:  Assay Drug Dev Technol       Date:  2015-07-20       Impact factor: 1.738

4.  Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.

Authors:  Olivia Perwitasari; Scott Johnson; Xiuzhen Yan; Elizabeth Howerth; Sharon Shacham; Yosef Landesman; Erkan Baloglu; Dilara McCauley; Sharon Tamir; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

5.  Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season.

Authors:  Jeffrey C Hageman; Timothy M Uyeki; John S Francis; Daniel B Jernigan; J Gary Wheeler; Carolyn B Bridges; Stephen J Barenkamp; Dawn M Sievert; Arjun Srinivasan; Meg C Doherty; Linda K McDougal; George E Killgore; Uri A Lopatin; Rebecca Coffman; J Kathryn MacDonald; Sigrid K McAllister; Gregory E Fosheim; Jean B Patel; L Clifford McDonald
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

Review 6.  Postviral Complications: Bacterial Pneumonia.

Authors:  Jason E Prasso; Jane C Deng
Journal:  Clin Chest Med       Date:  2016-12-13       Impact factor: 2.878

7.  Pneumonia severity index in viral community acquired pneumonia in adults.

Authors:  Mi-Ae Kim; Jae Seok Park; Choong Won Lee; Won-Il Choi
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

8.  Viewing the Community-acquired Pneumonia Guidelines through an Antibiotic Stewardship Lens.

Authors:  Valeria Fabre; Emily S Spivak; Sara C Keller
Journal:  Am J Respir Crit Care Med       Date:  2020-03-15       Impact factor: 21.405

9.  Combining adult with pediatric patient data to develop a clinical decision support tool intended for children: leveraging machine learning to model heterogeneity.

Authors:  Paul Sabharwal; Jillian H Hurst; Rohit Tejwani; Kevin T Hobbs; Jonathan C Routh; Benjamin A Goldstein
Journal:  BMC Med Inform Decis Mak       Date:  2022-03-29       Impact factor: 2.796

Review 10.  Virus-vectored influenza virus vaccines.

Authors:  Ralph A Tripp; S Mark Tompkins
Journal:  Viruses       Date:  2014-08-07       Impact factor: 5.048
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.